Overview of COVID-19 Vaccination Status in Patients Infected with COVID-19 at the Royal Prima General Hospital Medan

Lavenia Tri Setiani (Medical Education Student, Faculty of Medicine, Dentistry and Health Sciences, Universitas Prima Indonesia, Medan, Indonesia)
Wienaldi (Faculty of Medicine, Dentistry and Health Sciences, Universitas Prima Indonesia, Medan, Indonesia)
Wika Hanida Lubis (Faculty of Medicine, Dentistry and Health Sciences, Universitas Prima Indonesia, Medan, Indonesia)

Eureka Herba Indonesia
Vol. 4 No. 1 (2023): Eureka Herba Indonesia

Since the start of the COVID-19 pandemic, attempts have been made to provide acquired immunity against COVID-19. Monitoring and evaluating the efficacy and safety of the COVID-19 vaccine is an important process that must always be carried out in order to optimize the control of the spread of COVID-19 infection. This study aimed to provide an overview of the status of COVID-19 vaccination in patients infected with COVID-19 at the Royal Prima General Hospital, Medan, Indonesia. This study was a descriptive observational study. A total of 100 subjects participated in this study. Data analysis was performed using SPSS version 25 in a univariate manner. The majority of patients who have been vaccinated against COVID-19 only experience mild symptoms of COVID-19. The majority of vaccine brands used by confirmed COVID-19 patients are Sinovac. The majority of patients who have received 2 doses of vaccination are still at risk of being infected with COVID-19. The majority of patients who received the COVID-19 vaccination experienced a low clinical degree when infected with COVID-19.